Acyclovir as a Potential Add-on Therapy in COVID-19 Treatment Regimens

Fatemeh Heidary ¹ * , Sedigheh Madani ², Reza Gharebaghi ¹ * , Fahimeh Asadi-amoli ³

Cited by CrossRef: 6

1- Stewart D. Can Nitazoxanide and/or other anti‐viral medications be a solution to long COVID? Case report with a brief literature review. Clinical Case Reports. 2023;11(11) [Crossref]

2- Galal A, Ahmed Y, Ahmed M, Atta N. Electrochemistry and Determination of an Antiviral Drug at Ionic Liquids Crystals-Carbon Nanotubes Modified Glassy Carbon Electrode. J Electrochem Soc. 2021;168(11):116512 [Crossref]

3- Sanjay S, Kundu G, Deshpande V, Sethu S, Agrawal R, Ghosh A, Kawali A, Mahendradas P, Shetty R. Coronavirus disease 19 (COVID-19) and viral keratouveitis – unraveling the mystery. 2023;71(8):3103 [Crossref]

4- Singhal S, Sharma A, Malik A, Dahiya M, Singh Jadaun G, Patil V, Kaushik S. Development and Validation of In-vitro Release Study of Molnupiravir Capsules by RP-HPLC. CPA. 2023;19(7):577 [Crossref]

5- Gupta A, Vyas R. Evaluation of acyclovir adsorption on granular activated carbon from aqueous solutions: batch and fixed-bed parametric studies. Chem Pap. 2023;77(8):4599 [Crossref]

6- Tu H, Zhao L, Liu L, Wang X, Lin J, Wang X, Zhao R. Buchwald–Hartwig coupled conjugated microporous polymer for efficient removal COVID-19 antiviral drug famciclovir from waters: Adsorption behavior and mechanism. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2023;656:130393 [Crossref]

Submit Your Paper Editorial Board Instructions for Authors Instructions for Reviewers Contact Us Editorial Policies Peer Review Archive

Indexing & Abstracting:

Follow us on LinkedIn
Follow us on Twitter

Director-in-Charge:
Prof. Khosro Adibkia

Editor-in-Chief:
Prof. Ali Shayanfar

Follower of ICMJE